Cargando…
Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia
BACKGROUND: The introduction of a new and rapid molecular diagnostic for tuberculosis (TB) and rifampicin resistance (RIF) in the national TB program has improved the diagnosis of TB by shortening the turnaround time and detecting the presence of RIF resistance in high TB and human immunodeficiency...
Autores principales: | Ejeta, Eyasu, Beyene, Getenet, Bonsa, Zegeye, Abebe, Gemeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830166/ https://www.ncbi.nlm.nih.gov/pubmed/31720393 http://dx.doi.org/10.1016/j.jctube.2018.06.002 |
Ejemplares similares
-
Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia
por: Ejeta, Eyasu, et al.
Publicado: (2018) -
Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert(®) MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia
por: Admassu, Wasihun, et al.
Publicado: (2022) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)